Persistent inflammation, immunosuppression and catabolism syndrome (PICS): a new horizon for surgical critical care subtitle: cardiac dysfunction in older sepsis survivors subtitle: development of a designer Proline-Rich antimicrobial peptide chaperone protein inhibitor (DPC) for treating sepsis
NCT ID NCT02276417
First seen Sep 09, 2026 · Last updated Sep 09, 2026
Summary
The purpose of this study is to define the natural history and causes of chronic critical illness (CCI) in surgical intensive care patients who have had sepsis. The investigator also wants to define the long-term physical and cognitive outcomes of this disease. The investigator will be looking at many clinical variables to try to define CCI.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
668 people
The number who actually took part.
- Started
-
Jan 2015
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
We are looking at all patients admitted to the surgical and trauma ICUs that have been entered into the sepsis protocol.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * presence in the surgery or trauma intensive care unit (ICU) at University of Florida (UF) Health Shands Hospital where clinical care can be managed by surgical critical care guided by standard operating procedures. * age of ≥18 years * placed on EMR sepsis protocol with sepsis/septic shock by Sepsis-3 criteriad * ability to obtain informed consent. Exclusion Criteria: * patients deemed to be futile care or have advanced care directives or goals of care limiting resuscitative efforts. * severe traumatic brain injury (evidence of neurologic injury on CT scan and a Glasgow Coma Scale (GCS) \<8 after resuscitation). * refractory shock (i.e., patients who die within 12 hours). * uncontrollable source of sepsis (e.g., irreversible disease state such as unresectable dead bowel) * severe Congestive Heart Failure (CHF) (NY Heart Association Class IV) * severe chronic liver disease (Childs-Pugh Class B/C and /or MELD \> 14) or pre-liver transplant. * known HIV infection with CD4 count \<200 cells/mm3 * organ transplant recipient on immunosuppressive agents * known pregnancy * prisoners * institutionalized patients * inability to obtain informed consent. * pre-hospital bedridden status (WHO/Zubrod score ≥ 4). * patient's with an exacerbation of historic CVD or new onset CVD * alternative or confounding diagnosis causing shock state (e.g. MI or PE) * enrollment \> 96 hours after suspected sepsis onset. * pre-existing state of Chronic critical illness (ICU LOS ≥ 14 days, includes outside facility) * interfacility transfer patients with \> 96 hour critical illness prior to transfer. * subsequent clinical adjudication not consistent with sepsis/septic shock by Sepsis-3 criteria Healthy Controls Inclusion criteria will be: * all adults (age ≥18) * Ability to obtain Informed Consent prior to blood collection. Exclusion Criteria will be: * Current, chronic steroid use * Pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sepsis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UF Health Shands Hospital
Gainesville, Florida, 32610, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A randomized clinical trial of early empiric Anti-Mycobacterium tuberculosis therapy for sepsis in Sub-Saharan africa
- Tracing of real-time glu13Cose metabolism in human immune cells - intensive care unit
- Could a neck vein check replace a harder ultrasound for ICU fluid management?
- Sepsis alert system aims to speed up critical care response in hospitals
- Can tracking ambulance ventilators improve emergency breathing care?
- Can a simple blood test predict sepsis two days early?